|
US5530101A
(en)
*
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US20040101920A1
(en)
|
2002-11-01 |
2004-05-27 |
Czeslaw Radziejewski |
Modification assisted profiling (MAP) methodology
|
|
EP1740946B1
(en)
|
2004-04-20 |
2013-11-06 |
Genmab A/S |
Human monoclonal antibodies against cd20
|
|
US8257740B1
(en)
|
2011-08-15 |
2012-09-04 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles
|
|
US8246995B2
(en)
|
2005-05-10 |
2012-08-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells
|
|
JP2008539785A
(ja)
*
|
2005-05-16 |
2008-11-20 |
モルフォテック、インク. |
所望の表現型を示す細胞を選択するために制御されたベクター
|
|
ATE537190T1
(de)
|
2006-06-02 |
2011-12-15 |
Regeneron Pharma |
Hochaffine antikörper gegen den humanen il-6- rezeptor
|
|
CA2663388C
(en)
|
2006-09-07 |
2017-01-17 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
|
|
EP1947423A1
(en)
|
2007-01-16 |
2008-07-23 |
Sony Deutschland Gmbh |
Distance, orientation and velocity sensitive controller
|
|
JP5597128B2
(ja)
|
2007-05-11 |
2014-10-01 |
テマセック・ライフ・サイエンシズ・ラボラトリー・リミテッド |
H5トリインフルエンザの診断および監視に有用なh5亜型特異的結合タンパク質
|
|
US8383121B2
(en)
|
2007-09-13 |
2013-02-26 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof
|
|
JP5490695B2
(ja)
|
2007-09-13 |
2014-05-14 |
テマセック・ライフ・サイエンシズ・ラボラトリー・リミテッド |
インフルエンザウイルスh5亜型からのヘマグルチニンに特異的なモノクローナル抗体およびそれらの使用
|
|
EP3524619A1
(en)
|
2007-12-06 |
2019-08-14 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against influenza virus and methods of use thereof
|
|
JP5490725B2
(ja)
|
2008-02-05 |
2014-05-14 |
テマセック・ライフ・サイエンシズ・ラボラトリー・リミテッド |
H5亜型インフルエンザウイルスの普遍的な検出のための結合タンパク質およびエピトープブロッキングelisa
|
|
CA2719201A1
(en)
|
2008-03-28 |
2009-10-01 |
Sea Lane Biotechnologies, Llc. |
Neutralizing molecules to viral antigens
|
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
|
CA2731686C
(en)
|
2008-07-25 |
2020-04-07 |
Institute For Research In Biomedicine |
Neutralizing anti-influenza a virus antibodies and uses thereof
|
|
US20120128684A1
(en)
|
2008-08-25 |
2012-05-24 |
Burnham Institute For Medical Research |
Conserved Hemagglutinin Epitope, Antibodies to the Epitope and Methods of Use
|
|
AU2008365616A1
(en)
|
2008-12-24 |
2011-08-11 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza A viruses and uses thereof
|
|
EP2380976A4
(en)
|
2008-12-25 |
2012-11-07 |
Univ Osaka |
HUMAN ANTIBODY AGAINST HUMAN FLUX VIRUS
|
|
KR101790354B1
(ko)
|
2009-05-11 |
2017-10-25 |
얀센 백신스 앤드 프리벤션 비.브이. |
인플루엔자 바이러스 h3n2를 중화시킬 수 있는 인간 결합 분자 및 그것의 용도
|
|
US20120128671A1
(en)
|
2009-05-13 |
2012-05-24 |
Lawrence Horowitz |
Neutralizing molecules to influenza viruses
|
|
TWI507525B
(zh)
|
2009-06-26 |
2015-11-11 |
Regeneron Pharma |
具天然免疫球蛋白形式之易分離的雙專一性抗體
|
|
SG183149A1
(en)
|
2010-02-08 |
2012-09-27 |
Regeneron Pharma |
Common light chain mouse
|
|
CN102791734B
(zh)
|
2010-03-08 |
2014-10-15 |
赛特瑞恩股份有限公司 |
源自人b细胞且具有抗甲型流感病毒的中和活性的人单克隆抗体
|
|
RU2635999C2
(ru)
|
2010-06-17 |
2017-11-17 |
ТРЕЛЛИС БАЙОСАЙЕНС, ЭлЭлСи |
Антитела, подходящие для пассивной иммунизации против гриппа
|
|
US9534042B2
(en)
|
2010-09-03 |
2017-01-03 |
Fujita Health University |
Influenza virus-neutralizing antibody and screening method therefor
|
|
WO2012045001A2
(en)
|
2010-09-30 |
2012-04-05 |
Vanderbilt University |
Influenza virus antibodies and immunogens and uses therefor
|
|
EP2731967B1
(en)
|
2011-07-14 |
2016-10-12 |
Janssen Vaccines & Prevention B.V. |
Human binding molecules capable of neutralizing influenza a viruses of phylogenetic group 1 and phylogenetic group 2 and influenza b viruses
|
|
ITRM20110606A1
(it)
|
2011-11-16 |
2013-05-17 |
Ist Superiore Sanita |
Peptidi della lattoferrina per lo uso come inibitori ad ampio spettro dellainfezione da virus della influenza.
|
|
WO2013081463A2
(en)
|
2011-12-02 |
2013-06-06 |
Aimm Therapeutics B.V. |
Influenza a virus specific antibodies
|
|
MX367743B
(es)
|
2011-12-05 |
2019-09-04 |
Trellis Bioscience Llc |
Anticuerpos utiles para la inmunizacion pasiva de influenza.
|
|
MX360056B
(es)
|
2012-03-08 |
2018-10-19 |
Janssen Vaccines & Prevention Bv |
Moléculas de unión humanas que pueden unirse a los virus de la influenza b y neutralizarlos, y sus usos.
|
|
US9969794B2
(en)
|
2012-05-10 |
2018-05-15 |
Visterra, Inc. |
HA binding agents
|
|
BR112015010817A8
(pt)
|
2012-11-13 |
2018-01-23 |
Genentech Inc |
anticorpos anti-hemaglutinina isolado, método de tratamento, inibição ou prevenção de infecções, composição, composição farmacêutica, ácido nucleico isolado, célula hospedeira, método de produção de anticorpos e uso do anticorpo anti-hemaglutinina
|
|
TWI682941B
(zh)
|
2013-02-01 |
2020-01-21 |
美商再生元醫藥公司 |
含嵌合恆定區之抗體
|
|
KR20140118682A
(ko)
|
2013-03-29 |
2014-10-08 |
(주)셀트리온 |
2 이상의 인플루엔자 a 바이러스 중화 결합 분자를 포함하는 조성물
|
|
SG11201602522VA
(en)
*
|
2013-10-02 |
2016-04-28 |
Medimmune Llc |
Neutralizing anti-influenza a antibodies and uses thereof
|
|
AU2015214146B2
(en)
|
2014-02-04 |
2020-09-17 |
Contrafect Corporation |
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
|
|
MX2016012530A
(es)
|
2014-03-27 |
2017-01-05 |
Genentech Inc |
Anticuerpos de hemaglutinina contra el virus de la influenza b y metodos de uso.
|
|
CN104031118B
(zh)
|
2014-06-19 |
2016-04-13 |
天津大学 |
鼠多瘤病毒衣壳粒的新型亲和肽配基及其设计筛选方法
|
|
TWI701258B
(zh)
|
2014-12-19 |
2020-08-11 |
美商再生元醫藥公司 |
流行性感冒病毒血球凝集素之人類抗體
|
|
US10435462B2
(en)
|
2015-03-31 |
2019-10-08 |
Viro Dynamics Corporation |
Hybrid influenza seed viruses, compositions thereof, and use thereof in the diagnosis or therapy of influenza
|
|
US11135282B2
(en)
|
2015-04-08 |
2021-10-05 |
Dana-Farber Cancer Institute, Inc. |
Humanized influenza monoclonal antibodies and methods of use thereof
|
|
MX389708B
(es)
|
2015-06-01 |
2025-03-20 |
Medimmune Llc |
Neutralizacion de moleculas de union anti-influenza y usos de las mismas.
|
|
WO2017192589A1
(en)
*
|
2016-05-02 |
2017-11-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Neutralizing antibodies to influenza ha and their use and identification
|
|
WO2020221450A1
(en)
|
2019-04-30 |
2020-11-05 |
Humabs Biomed Sa |
Antibodies and methods for treatment of influenza a infection
|